BioCapital China Summit 2008 - Beijing

October 24, 2008
Beijing International Convention Center

This one-day Summit to be held in conjunction with Beijing’s premier life science conference, the 12th Annual Healthcare Industry Forum, will explore the state of China’s rapidly growing biotech industry and the financial drivers that will determine its success, including:

    Early Stage Funding
    Venture Capital Investment
    Collaboration & Licensing Deals
    IPOs and M&A Activity

Website: www.biocapital2008.com

Program

Speakers from around the world will present insights and analysis into the current state of the industry, the factors critical to its success, and its rapidly evolving future. Topics will include:

     The State of China’s Biotech Industry 
     Financial Drivers of China Biotech
     Raising Venture Capital 
     Doing Deals: Collaboration and Licensing
     Exiting: M&A and IPO Transactions 
     2020: A Look at the Future of China Biotech

For a complete agenda please click here.

Who Should Attend

Held in conjunction with the 12th Annual Healthcare Industry Forum, attendees will include executives and key leaders from the firms and organizations shaping China's biotech industry.  You should attend if you're a:

     Venture Capitalist
     Industry Analyst
     Fund manager
     Investment Banker
     Private Equity Investor
     Pharma Executive
     Biotech Entrepreneur

Speakers

Experts who have hands-on experience in the China life science industry will speak oninclude:

     Industry Leaders
     Venture Capitalists
     Investment Bankers
     MNC Pharma Executives
     Biotech Executives

For a complete list of speakers, please click here.

Speakers confirmed to date include:

     Greg B. Scott, President and Founder - ChinaBio@ Accelerator
     Carl Firth, PhD, MBA, Vice President, Asia - Merrill Lynch
     Alex Fowkes, JD, Head of R&D Business Development, Asia - Pfizer
     Jennifer Hu, PhD, Director of Licensing and Alliances - Merck & Co.
     Rebecca Lin, MBA, Vice President - Fidelity Asia Ventures
     David Xu, PhD, Managing Partner - Mingly China Growth Fund
     Chika Yoshinaga, PhD, VP Asia - Sofinnova
     Wei Zhou, PhD, JD, Partner - Wilson Sonsini Goodrich & Rosati

Registration

You may register for just the BioCapital China Summit or for the complete Healthcare Industry Forum.  Registration fees are:

BioCapital China Summit:  Only $400!

Healthcare Industry Forum:  Regularly $1500   Early bird from ChinaBio only $800!  Includes the full HIF program and the BioCapital China Summit.

Registration coming soon!

Organizers

Beijing Pharma & Biotech Center (BPBC)
ChinaBio? Accelerator – Creators of the ChinaBio? Investor Forums

For More Information...

For more information on the Healthcare Industry Forum to be held October 22-24, please see www.hif.com.cn/en.  (Organized by Beijing Pharma & Biotech Center)

For more information on other upcoming ChinaBio? events, please click here or see www.ChinaBio-Events.com. 

Or please contact us for more information.